Literature DB >> 17538963

Good fat/bad fat.

Craig J McClain, Shirish Barve, Ion Deaciuc.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17538963     DOI： 10.1002/hep.21788

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  32 in total

Review 1.  Common Medications Which Lead to Unintended Alterations in Weight Gain or Organ Lipotoxicity.

Authors:  Valentina Medici; Stephen A McClave; Keith R Miller
Journal:  Curr Gastroenterol Rep       Date:  2016-01

2.  Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis.

Authors:  Jamie E Mells; Ping P Fu; Pradeep Kumar; Tekla Smith; Saul J Karpen; Frank A Anania
Journal:  J Nutr Biochem       Date:  2014-12-06       Impact factor: 6.048

3.  Nonalcoholic fatty liver disease: from lipid profile to treatment.

Authors:  Kouichi Miura; Hirohide Ohnishi
Journal:  Clin J Gastroenterol       Date:  2012-06-17

4.  Lipidomic changes in rat liver after long-term exposure to ethanol.

Authors:  Harshica Fernando; Kamlesh K Bhopale; Shakuntala Kondraganti; Bhupendra S Kaphalia; G A Shakeel Ansari
Journal:  Toxicol Appl Pharmacol       Date:  2011-06-26       Impact factor: 4.219

5.  Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet.

Authors:  Jamie E Mells; Ping P Fu; Shvetank Sharma; Darin Olson; Lihong Cheng; Jeffrey A Handy; Neeraj K Saxena; Dan Sorescu; Frank A Anania
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-10-28       Impact factor: 4.052

6.  Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice.

Authors:  Yehuda Kamari; Aviv Shaish; Einav Vax; Shay Shemesh; Michal Kandel-Kfir; Yaron Arbel; Sarita Olteanu; Iris Barshack; Shahar Dotan; Elana Voronov; Charles A Dinarello; Ron N Apte; Dror Harats
Journal:  J Hepatol       Date:  2011-02-24       Impact factor: 25.083

Review 7.  From NAFLD to NASH to cirrhosis-new insights into disease mechanisms.

Authors:  Alexander Wree; Lori Broderick; Ali Canbay; Hal M Hoffman; Ariel E Feldstein
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-08-20       Impact factor: 46.802

8.  Age impacts ability of aspartate-alanine aminotransferase ratio to predict advanced fibrosis in nonalcoholic Fatty liver disease.

Authors:  George Boon-Bee Goh; Mangesh R Pagadala; Jaividhya Dasarathy; Aynur Unalp-Arida; Rish K Pai; Lisa Yerian; Amer Khiyami; Achuthan Sourianarayanane; Ruth Sargent; Carol Hawkins; Srinivasan Dasarathy; Arthur J McCullough
Journal:  Dig Dis Sci       Date:  2015-02-24       Impact factor: 3.199

Review 9.  Pre-and-post transplant considerations in patients with nonalcoholic fatty liver disease.

Authors:  Vikas Khullar; Angela Dolganiuc; Roberto J Firpi
Journal:  World J Transplant       Date:  2014-06-24

Review 10.  Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal.

Authors:  Naim Alkhouri; Laura J Dixon; Ariel E Feldstein
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2009-08       Impact factor: 3.869
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.